Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces Positive Data from Head to Head Adhesion Study with its Lead Product, ZTlido(TM)

Stock Information for Sorrento Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.